ข่าวประชาสัมพันธ์ CIBA Vision

CIBA VISION KEEPS YOUR EYES YOUNG AND HEALTHY WITH AIR OPTIX AQUA

Mr. Nopporn Phatthararuchi, CIBA Vision (Thailand) Commercial Director, has introduced Air Optix Aqua – an innovative contact lens based on silicone hydrogel material with patented surface treatment technology for the ultimate in clear vision, cleanliness and comfort. This breathable contact lens, well-known internationally for having five times the oxygen transmissibility of general soft lenses, is a product that fits perfectly with the modern lifestyle while also providing valuable cornea

AsiaNet Daily Summary - Press Releases for Thursday June 27, 2002

MONEY TRANSFERS... TORONTO: A new Person-to-Person money transfer service Email Money Transfers, using emails to notify customers when banks transfer their funds, is being offered by a number of financial institutions in Canada, a...

ASIANET: CIBA Vision Announces Completion Of Acquisition of Wesley Jessen

CIBA Vision Announces Completion Of Acquisition of Wesley Jessen Combined Company Ranks Number Two Worldwide in Contact Lenses ATLANTA, Oct. 3 /PRNewswire-AsiaNet/ CIBA Vision Corporation, the eye care unit of Novartis AG (NYSE...

ASIANET : Novartis Agrees to Acquire Wesley Jessen VisionCare For $38.50 Per Share in Cash

Novartis Agrees to Acquire Wesley Jessen Vision Care For $38.50 Per Share in Cash Combined Company Will Rank Number Two Worldwide in Contact Lenses ATLANTA and DES PLAINES, Ill., May 30 /PRNewswire-AsiaNet/...

ASIANET: FDA Approves Visudyne(TM) Therapy For AMD

FDA Approves Visudyne(TM) Therapy For AMD; A Major Advance in Ophthalmology ATLANTA and VANCOUVER, British Columbia, April 12 /PRNewswire-AsiaNet/ CIBA Vision, the eye care unit of Novartis, and QLT PhotoTherapeutics Inc. (Nasdaq: QLTI; Toronto)...

ASIANET: FDA Takes Positive Action as Visudyne Review Nears Completion

FDA Takes Positive Action as Visudyne Review Nears Completion ATLANTA and VANCOUVER, British Columbia, Feb. 11 /PRNewswire-AsiaNet/ CIBA Vision, the eye care unit of Novartis, and QLT PhotoTherapeutics Inc. (Nasdaq: QLTI)...